85 related articles for article (PubMed ID: 10854535)
1. In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-beta stimulated clone-22.
Omotehara F; Uchida D; Hino S; Begum NM; Yoshida H; Sato M; Kawamata H
Oncol Rep; 2000; 7(4):737-40. PubMed ID: 10854535
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of TSC-22 (TGF-beta stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line.
Uchida D; Kawamata H; Omotehara F; Miwa Y; Hino S; Begum NM; Yoshida H; Sato M
Lab Invest; 2000 Jun; 80(6):955-63. PubMed ID: 10879745
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
[TBL] [Abstract][Full Text] [Related]
4. TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancer.
Kawamata H; Fujimori T; Imai Y
Curr Cancer Drug Targets; 2004 Sep; 4(6):521-9. PubMed ID: 15379637
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic TSC-22 (transforming growth factor-beta-stimulated clone-22) markedly enhances the radiation sensitivity of salivary gland cancer cells.
Hino S; Kawamata H; Omotehara F; Uchida D; Miwa Y; Begum NM; Yoshida H; Sato M; Fujimori T
Biochem Biophys Res Commun; 2002 Apr; 292(4):957-63. PubMed ID: 11944908
[TBL] [Abstract][Full Text] [Related]
6. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.
Kawamata H; Nakashiro K; Uchida D; Hino S; Omotehara F; Yoshida H; Sato M
Br J Cancer; 1998; 77(1):71-8. PubMed ID: 9459148
[TBL] [Abstract][Full Text] [Related]
7. Leucine zipper structure of TSC-22 (TGF-beta stimulated clone-22) markedly inhibits the anchorage-independent growth of salivary gland cancer cells.
Hino S; Kawamata H; Omotehara F; Uchida D; Begum NM; Yoshida H; Sato M; Fujimori T
Oncol Rep; 2002; 9(2):371-4. PubMed ID: 11836610
[TBL] [Abstract][Full Text] [Related]
8. Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.
Sato M; Kawamata H; Harada K; Nakashiro K; Ikeda Y; Gohda H; Yoshida H; Nishida T; Ono K; Kinoshita M; Adachi M
Cancer Lett; 1997 Jan; 112(2):181-9. PubMed ID: 9066726
[TBL] [Abstract][Full Text] [Related]
9. Expression and cellular localization of TSC-22 in normal salivary glands and salivary gland tumors: implications for tumor cell differentiation.
Doi Y; Kawamata H; Ono Y; Fujimori T; Imai Y
Oncol Rep; 2008 Mar; 19(3):609-16. PubMed ID: 18288391
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation of TSC-22 (TGF-beta-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator.
Hino S; Kawamata H; Uchida D; Omotehara F; Miwa Y; Begum NM; Yoshida H; Fujimori T; Sato M
Biochem Biophys Res Commun; 2000 Nov; 278(3):659-64. PubMed ID: 11095965
[TBL] [Abstract][Full Text] [Related]
11. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
[TBL] [Abstract][Full Text] [Related]
12. Lack of expression of transforming growth factor-beta type II receptor associated with malignant progression in human salivary gland cell clones.
Azuma M; Yuki T; Tamatani T; Motegi K; Yoshida H; Sato M
Int J Cancer; 1996 Jun; 66(6):802-5. PubMed ID: 8647653
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice.
Sato M; Harada K; Bando T; Shirakami T; Nakashiro K; Yoshida H; Nakai S; Kawai K; Adachi M
Cancer Lett; 1995 May; 91(1):1-9. PubMed ID: 7750082
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of apoptotic cell death of human gastric carcinoma cells mediated by transforming growth factor beta.
Ohta S; Yanagihara K; Nagata K
Biochem J; 1997 Jun; 324 ( Pt 3)(Pt 3):777-82. PubMed ID: 9210400
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line.
Omotehara F; Nakashiro K; Uchida D; Hino S; Fujimori T; Kawamata H
J Exp Clin Cancer Res; 2003 Mar; 22(1):57-60. PubMed ID: 12725323
[TBL] [Abstract][Full Text] [Related]
16. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
17. TSC-22 Promotes Interleukin-2-Deprivation Induced Apoptosis in T-Lymphocytes.
Pépin A; Espinasse MA; Latré de Laté P; Szely N; Pallardy M; Biola-Vidamment A
J Cell Biochem; 2016 Aug; 117(8):1855-68. PubMed ID: 26752201
[TBL] [Abstract][Full Text] [Related]
18. Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line.
Omotehara F; Kawamata H; Uchida D; Hino S; Nakashiro K; Fujimori T
Br J Cancer; 2002 Oct; 87(9):1042-6. PubMed ID: 12434298
[TBL] [Abstract][Full Text] [Related]
19. Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22.
Lee JH; Rho SB; Park SY; Chun T
FEBS Lett; 2008 Apr; 582(8):1210-8. PubMed ID: 18325344
[TBL] [Abstract][Full Text] [Related]
20. Effects of folylpolyglutamate synthetase modulation on chemosensitivity of colon cancer cells to 5-fluorouracil and methotrexate.
Sohn KJ; Smirnakis F; Moskovitz DN; Novakovic P; Yates Z; Lucock M; Croxford R; Kim YI
Gut; 2004 Dec; 53(12):1825-31. PubMed ID: 15542523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
